177 related articles for article (PubMed ID: 33676976)
1. Synergistic neuroprotective effects of Fingolimod and mesenchymal stem cells (MSC) in experimental autoimmune encephalomyelitis.
Kassis I; Ben-Zwi M; Petrou P; Halimi M; Karussis D
Immunol Lett; 2021 May; 233():11-19. PubMed ID: 33676976
[TBL] [Abstract][Full Text] [Related]
2. Effect of Fingolimod on Neural Stem Cells: A Novel Mechanism and Broadened Application for Neural Repair.
Zhang Y; Li X; Ciric B; Ma CG; Gran B; Rostami A; Zhang GX
Mol Ther; 2017 Feb; 25(2):401-415. PubMed ID: 28153091
[TBL] [Abstract][Full Text] [Related]
3. Effective combination of human bone marrow mesenchymal stem cells and minocycline in experimental autoimmune encephalomyelitis mice.
Hou Y; Ryu CH; Park KY; Kim SM; Jeong CH; Jeun SS
Stem Cell Res Ther; 2013 Jul; 4(4):77. PubMed ID: 23826999
[TBL] [Abstract][Full Text] [Related]
4. Intranasal administration of small extracellular vesicles derived from mesenchymal stem cells ameliorated the experimental autoimmune encephalomyelitis.
Fathollahi A; Hashemi SM; Haji Molla Hoseini M; Tavakoli S; Farahani E; Yeganeh F
Int Immunopharmacol; 2021 Jan; 90():107207. PubMed ID: 33290966
[TBL] [Abstract][Full Text] [Related]
5. Immunomodulation Eliminates Inflammation in the Hippocampus in Experimental Autoimmune Encephalomyelitis, but Does Not Ameliorate Anxiety-Like Behavior.
Kocovski P; Tabassum-Sheikh N; Marinis S; Dang PT; Hale MW; Orian JM
Front Immunol; 2021; 12():639650. PubMed ID: 34177891
[TBL] [Abstract][Full Text] [Related]
6. Mesenchymal stem cells (MSC) derived from mice with experimental autoimmune encephalomyelitis (EAE) suppress EAE and have similar biological properties with MSC from healthy donors.
Kassis I; Petrou P; Halimi M; Karussis D
Immunol Lett; 2013; 154(1-2):70-6. PubMed ID: 23994102
[TBL] [Abstract][Full Text] [Related]
7. The immunomodulatory and neuroprotective effects of mesenchymal stem cells (MSCs) in experimental autoimmune encephalomyelitis (EAE): a model of multiple sclerosis (MS).
Al Jumah MA; Abumaree MH
Int J Mol Sci; 2012; 13(7):9298-9331. PubMed ID: 22942767
[TBL] [Abstract][Full Text] [Related]
8. Combining miR-23b exposure with mesenchymal stem cell transplantation enhances therapeutic effects on EAE.
Hu R; Lv W; Zhang S; Liu Y; Sun B; Meng Y; Kong Q; Mu L; Wang G; Zhang Y; Li H; Liu X
Immunol Lett; 2021 Jan; 229():18-26. PubMed ID: 33238163
[TBL] [Abstract][Full Text] [Related]
9. FTY720 (fingolimod) efficacy in an animal model of multiple sclerosis requires astrocyte sphingosine 1-phosphate receptor 1 (S1P1) modulation.
Choi JW; Gardell SE; Herr DR; Rivera R; Lee CW; Noguchi K; Teo ST; Yung YC; Lu M; Kennedy G; Chun J
Proc Natl Acad Sci U S A; 2011 Jan; 108(2):751-6. PubMed ID: 21177428
[TBL] [Abstract][Full Text] [Related]
10. The effects of transplanted mesenchymal stem cells treated with 17-b estradiol on experimental autoimmune encephalomyelitis.
Heidari Barchi Nezhad R; Asadi F; Abtahi Froushani SM; Hassanshahi G; Kaeidi A; Khanamani Falahati-Pour S; Hashemi Z; Mirzaei MR
Mol Biol Rep; 2019 Dec; 46(6):6135-6146. PubMed ID: 31555971
[TBL] [Abstract][Full Text] [Related]
11. Clozapine Regulates Microglia and Is Effective in Chronic Experimental Autoimmune Encephalomyelitis.
Ceylan U; Haupeltshofer S; Kämper L; Dann J; Ambrosius B; Gold R; Faissner S
Front Immunol; 2021; 12():656941. PubMed ID: 34012440
[TBL] [Abstract][Full Text] [Related]
12. Rapamycin Augments Immunomodulatory Properties of Bone Marrow-Derived Mesenchymal Stem Cells in Experimental Autoimmune Encephalomyelitis.
Togha M; Jahanshahi M; Alizadeh L; Jahromi SR; Vakilzadeh G; Alipour B; Gorji A; Ghaemi A
Mol Neurobiol; 2017 May; 54(4):2445-2457. PubMed ID: 26971291
[TBL] [Abstract][Full Text] [Related]
13. Fingolimod treatment promotes proliferation and differentiation of oligodendrocyte progenitor cells in mice with experimental autoimmune encephalomyelitis.
Zhang J; Zhang ZG; Li Y; Ding X; Shang X; Lu M; Elias SB; Chopp M
Neurobiol Dis; 2015 Apr; 76():57-66. PubMed ID: 25680941
[TBL] [Abstract][Full Text] [Related]
14. AKP-11 - A Novel S1P1 Agonist with Favorable Safety Profile Attenuates Experimental Autoimmune Encephalomyelitis in Rat Model of Multiple Sclerosis.
Samuvel DJ; Saxena N; Dhindsa JS; Singh AK; Gill GS; Grobelny DW; Singh I
PLoS One; 2015; 10(10):e0141781. PubMed ID: 26513477
[TBL] [Abstract][Full Text] [Related]
15. Fingolimod may support neuroprotection via blockade of astrocyte nitric oxide.
Colombo E; Di Dario M; Capitolo E; Chaabane L; Newcombe J; Martino G; Farina C
Ann Neurol; 2014 Sep; 76(3):325-37. PubMed ID: 25043204
[TBL] [Abstract][Full Text] [Related]
16. Distinct immunomodulatory and migratory mechanisms underpin the therapeutic potential of human mesenchymal stem cells in autoimmune demyelination.
Payne NL; Sun G; McDonald C; Layton D; Moussa L; Emerson-Webber A; Veron N; Siatskas C; Herszfeld D; Price J; Bernard CC
Cell Transplant; 2013; 22(8):1409-25. PubMed ID: 23057962
[TBL] [Abstract][Full Text] [Related]
17. The Crotoxin:SBA-15 Complex Down-Regulates the Incidence and Intensity of Experimental Autoimmune Encephalomyelitis Through Peripheral and Central Actions.
Sant'Anna MB; Giardini AC; Ribeiro MAC; Lopes FSR; Teixeira NB; Kimura LF; Bufalo MC; Ribeiro OG; Borrego A; Cabrera WHK; Ferreira JCB; Zambelli VO; Sant'Anna OA; Picolo G
Front Immunol; 2020; 11():591563. PubMed ID: 33193433
[TBL] [Abstract][Full Text] [Related]
18. Neuroprotection and immunomodulation with mesenchymal stem cells in chronic experimental autoimmune encephalomyelitis.
Kassis I; Grigoriadis N; Gowda-Kurkalli B; Mizrachi-Kol R; Ben-Hur T; Slavin S; Abramsky O; Karussis D
Arch Neurol; 2008 Jun; 65(6):753-61. PubMed ID: 18541795
[TBL] [Abstract][Full Text] [Related]
19. Activation of Glucagon-Like Peptide-1 Receptor Promotes Neuroprotection in Experimental Autoimmune Encephalomyelitis by Reducing Neuroinflammatory Responses.
Lee CH; Jeon SJ; Cho KS; Moon E; Sapkota A; Jun HS; Ryu JH; Choi JW
Mol Neurobiol; 2018 Apr; 55(4):3007-3020. PubMed ID: 28456941
[TBL] [Abstract][Full Text] [Related]
20. IFNβ enhances mesenchymal stromal (Stem) cells immunomodulatory function through STAT1-3 activation and mTOR-associated promotion of glucose metabolism.
Vigo T; La Rocca C; Faicchia D; Procaccini C; Ruggieri M; Salvetti M; Centonze D; Matarese G; Uccelli A;
Cell Death Dis; 2019 Jan; 10(2):85. PubMed ID: 30692524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
